Clincosm LogoSign in Get a demo

stage iiib breast cancer

Showing 26 - 50 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Duarte (radiation, other,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +3 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +5 more
  • Duarte, California
    City of Hope Medical Center
May 17, 2021

Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer Trial in Orange (Carboplatin, paclitaxel

Active, not recruiting
  • Breast Cancer
  • +9 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 14, 2021

Cancer Survivor, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in New Brunswick (Behavioral Dietary Intervention,

Completed
Has Results
  • Cancer Survivor
  • +8 more
  • Behavioral Dietary Intervention
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Robert Wood Johnson Medical School
Apr 9, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer Trial in Los Angeles (Exercise Intervention, Laboratory

Terminated
  • Stage IA Breast Cancer
  • +6 more
  • Exercise Intervention
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Apr 1, 2021

Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (tipifarnib, paclitaxel, doxorubicin)

Completed
Has Results
  • Breast Cancer
  • +5 more
  • Tampa, Florida
  • +6 more
Jan 29, 2021

Anxiety Disorder, Depression, Recurrent Breast Cancer Trial in Columbus (minocycline HCl, , laboratory biomarker analysis)

Active, not recruiting
  • Anxiety Disorder
  • +8 more
  • minocycline hydrochloride
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jan 14, 2021

Breast Adenocarcinoma, Estrogen Receptor Positive, HER2/Neu Negative Trial in Tampa, Bronx (drug, other, procedure)

Terminated
  • Breast Adenocarcinoma
  • +8 more
  • Tampa, Florida
  • +1 more
Sep 22, 2020

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications Trial in Los Angeles (mucoadhesive

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • mucoadhesive oral wound rinse
  • laboratory biomarker analysis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 17, 2020

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

Unknown status
Has Results
  • Estrogen Receptor Negative
  • +9 more
  • Chicago, Illinois
  • +1 more
Jun 25, 2020

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago (drug, biological, other)

Completed
Has Results
  • HER2-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 25, 2020

Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Columbus (dietary supplement, other, procedure)

Unknown status
  • Recurrent Breast Cancer
  • +6 more
  • omega-3 fatty acid supplement
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2020

Peripheral Neuropathy, Stage 0 Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (procedure, other, diagnostic test)

Completed
  • Peripheral Neuropathy
  • +12 more
  • Biopsy
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
May 8, 2020

Cancer Survivor, No Evidence of Disease, Obesity Trial in Los Angeles (behavioral, other, device)

Terminated
  • Cancer Survivor
  • +15 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
May 9, 2020

Breast Cancer, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Philadelphia (acupuncture therapy, sham intervention)

Completed
  • Breast Cancer
  • +6 more
  • acupuncture therapy
  • sham intervention
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Apr 7, 2020

HER2-positive Breast Cancer, Male Breast Cancer, Stage IIIB Breast Cancer Trial in Seattle (biological, procedure, other)

Completed
  • HER2-positive Breast Cancer
  • +4 more
  • HER-2/neu intracellular domain protein
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 7, 2020

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Cancer Survivor, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Cleveland (One-on-one interview, Survey Questions)

Completed
  • Cancer Survivor
  • +7 more
  • One-on-one interview
  • Survey Questions
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jan 2, 2020

Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer Trial in Cleveland, Columbus

Unknown status
  • Estrogen Receptor and/or Progesterone Receptor Positive
  • +8 more
  • Cleveland, Ohio
  • +1 more
Dec 18, 2019

Cancer Survivor, Healthy Subject, Stage I Colorectal Cancer Trial in Madison (Educational Intervention, Internet-Based

Completed
  • Cancer Survivor
  • +15 more
  • Educational Intervention
  • +4 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 14, 2019

Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Male Breast Cancer Trial in Winston-Salem (omega-3 fatty

Completed
Has Results
  • Ductal Breast Carcinoma in Situ
  • +8 more
  • omega-3 fatty acid
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 7, 2019

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +7 more
  • Bethesda, Maryland
  • +2 more
Oct 7, 2019

Cancer Survivor, Central Obesity, Estrogen Receptor Positive Trial in Los Angeles (Exercise Intervention, Informational

Withdrawn
  • Cancer Survivor
  • +14 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Oct 21, 2019

Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,

Terminated
  • Chemotherapeutic Agent Toxicity
  • +11 more
  • cryotherapy
  • +4 more
  • Chicago, Illinois
    Northwestern University
Aug 16, 2019

Inflammatory Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (drug, biological, procedure,

Completed
Has Results
  • Inflammatory Breast Cancer
  • +5 more
  • sunitinib malate
  • +7 more
  • Anchorage, Alaska
  • +6 more
Jul 23, 2019